These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2405105)

  • 1. Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.
    Browman GP; Goodyear MD; Levine MN; Russell R; Archibald SD; Young JE
    J Clin Oncol; 1990 Feb; 8(2):203-8. PubMed ID: 2405105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate/fluorouracil scheduling influences normal tissue toxicity but not antitumor effects in patients with squamous cell head and neck cancer: results from a randomized trial.
    Browman GP; Levine MN; Goodyear MD; Russell R; Archibald SD; Jackson BS; Young JE; Basrur V; Johanson C
    J Clin Oncol; 1988 Jun; 6(6):963-8. PubMed ID: 3286831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High dose methotrexate with CF rescue therapy in patients with head and neck cancer].
    Inuyama Y; Taketa C; Hiroto I; Fujii M; Takaoka T; Tanaka J; Matsuura S; Satake B; Takeoda S; Nishijima W
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1823-31. PubMed ID: 6332576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer.
    Browman GP; Archibald SD; Young JE; Hryniuk WM; Russell R; Kiehl K; Levine MN
    J Clin Oncol; 1983 Dec; 1(12):787-92. PubMed ID: 6366132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H; Tsukuda M; Taguchi T
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate treatment of advanced head and neck cancers: a dose response evaluation.
    Woods RL; Fox RM; Tattersall MH
    Cancer Treat Rep; 1981; 65 Suppl 1():155-9. PubMed ID: 7034929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
    J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of carboplatin plus methotrexate versus methotrexate alone in patients with recurrent and metastatic head and neck cancer.
    Eisenberger M; Krasnow S; Ellenberg S; Silva H; Abrams J; Sinibaldi V; Van Echo D; Aisner J
    J Clin Oncol; 1989 Sep; 7(9):1341-5. PubMed ID: 2671289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Moderate dose methotrexate with citrovorum factor rescue therapy in the treatment of head and neck cancer].
    Inuyama Y; Hiroto I; Taketa C; Horiuchi M; Mashino S; Fujii M; Matsuura S; Satake B; Takeoda S; Nishijima W; Okuda M; Sakaguchi K; Tanigaito Y; Imakirei M; Konno T; Hirokawa T; Takada K; Ono I; Saitoh H; Takemiya S; Shimada F; Omura K; Miyake H; Fujii K; Kawabe Y; Kondoh T; Komiyama S; Yanagida T; Matsumura Y; Hirano M; Araki S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2193-200. PubMed ID: 6764099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined MTX.5-FU.CDGP for the treatment of head and neck cancer].
    Sakoda T; Saitoh Y; Seno S; Ikeda H; Dake Y; Enomoto T; Kawano A; Kitano H
    Gan To Kagaku Ryoho; 2003 May; 30(5):641-5. PubMed ID: 12795095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced colorectal carcinoma. A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leucovorin versus 5-fluorouracil alone.
    Machiavelli M; Leone BA; Romero A; Rabinovich MG; Vallejo CT; Bianco A; Pérez JE; Rodríguez R; Cuevas MA; Alvarez LA
    Am J Clin Oncol; 1991 Jun; 14(3):211-7. PubMed ID: 2031508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized comparison of high-dose infusion methotrexate versus standard-dose weekly therapy in head and neck squamous cancer.
    Taylor SG; McGuire WP; Hauck WW; Showel JL; Lad TE
    J Clin Oncol; 1984 Sep; 2(9):1006-11. PubMed ID: 6332178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck.
    Colella E; Merlano M; Blengio F; Angelini F; Ausili Cefaro GP; Scasso F; Lo Russo V; Cirulli S; Giannarelli D; Cognetti F
    Eur J Cancer; 1994; 30A(7):928-30. PubMed ID: 7946585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group study.
    Schornagel JH; Verweij J; de Mulder PH; Cognetti F; Vermorken JB; Cappelaere P; Armand JP; Wildiers J; de Graeff A; Clavel M
    J Clin Oncol; 1995 Jul; 13(7):1649-55. PubMed ID: 7602354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study.
    Jacobs C; Meyers F; Hendrickson C; Kohler M; Carter S
    Cancer; 1983 Nov; 52(9):1563-9. PubMed ID: 6352004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial adjuvant therapy in advanced squamous cell carcinoma of the head and neck employing weekly high dose methotrexate with leucovorin rescue.
    Pitman SW; Miller D; Weichselbaum R
    Laryngoscope; 1978 Apr; 88(4):632-8. PubMed ID: 306011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC; Fabian RL
    Laryngoscope; 1992 Aug; 102(8):901-6. PubMed ID: 1379664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas--a prospective, randomized study.
    Rentschler RE; Wilbur DW; Petti GH; Chonkich GD; Hilliard DA; Camacho ES; Thorpe RB
    J Clin Oncol; 1987 Feb; 5(2):278-85. PubMed ID: 3806169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate and 5-fluorouracil in sequence in squamous head and neck cancer.
    Pitman SW; Kowal CD; Bertino JR
    Semin Oncol; 1983 Jun; 10(2 Suppl 2):15-9. PubMed ID: 6346497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
    Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
    Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.